Werewolf Therapeutics, Inc. · NASDAQ:HOWL

Luke Evnin sold 171,049 Werewolf Therapeutics, Inc. shares (Form 4)

Traded May 18 to May 20, 2026 · Filed May 20, 2026

From May 18 to May 20, 2026, Luke Evnin (Director) sold 171,049 Werewolf Therapeutics, Inc. shares at an average US$0.45 for US$76,363 under a trading plan, leaving 955,447 shares. Filed May 20, 2026 (Form 4).

Sold
171,049 shares
Price
US$0.45 average (US$0.43 to US$0.50)
Value
US$76,363
Holding after
955,447 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 18, 2026Common StockSale22,184US$0.501,104,312Indirect
May 19, 2026Common StockSale62,970US$0.451,041,342Indirect
May 20, 2026Common StockSale85,895US$0.43955,447Indirect

Source

View original at SEC

Related